Literature DB >> 3645972

Staphylococcus aureus bacteremia caused by infected intravenous catheters.

J M Mylotte, C McDermott.   

Abstract

A prospective study of all cases of Staphylococcus aureus bacteremia (SAB) has been ongoing at our institution since April 1983. Data collected as of December 1984 reveal that of 79 episodes of SAB identified, 28 (35%) were caused by infected intravenous catheters; 14 of these were peripheral catheters and 14 were subclavian catheters. Endocarditis or metastatic infection was not recognized; two patients, one with a prosthetic heart valve and the other with recurrent SAB, did not meet the criteria for these complications but the clinical circumstances were strongly suggestive. Six of the 28 patients (21%) died of their infection, and local complications (inflammation or purulent drainage at the insertion site) were common. Only four of 22 patients who recovered were administered antibiotics for greater than 14 days. We conclude that patients with SAB caused by an infected intravenous catheter have a low risk of endocarditis or metastatic infection when the infected catheter is promptly removed and no risk factors (valvular heart disease or a prosthetic valve) are present that favor development of endocarditis. The duration of antimicrobial therapy need not exceed 2 weeks in this situation. The mortality related to SAB, however, was high and emphasizes the need to develop methods to prevent this infection.

Entities:  

Mesh:

Year:  1987        PMID: 3645972     DOI: 10.1016/0196-6553(87)90069-1

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  9 in total

Review 1.  Biofilms in device-related infections.

Authors:  N Khardori; M Yassien
Journal:  J Ind Microbiol       Date:  1995-09

2.  Efficacy of dicloxacillin-coated polyurethane catheters in preventing subcutaneous Staphylococcus aureus infection in mice.

Authors:  R J Sherertz; D M Forman; D D Solomon
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

Review 3.  Predictors of mortality in Staphylococcus aureus Bacteremia.

Authors:  Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

Review 4.  Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Authors:  Steven Y C Tong; Joshua S Davis; Emily Eichenberger; Thomas L Holland; Vance G Fowler
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

5.  Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients.

Authors:  I Raad; J Narro; A Khan; J Tarrand; S Vartivarian; G P Bodey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-08       Impact factor: 3.267

Review 6.  Clinical implications of positive blood cultures.

Authors:  C S Bryan
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

7.  Risk Factors and Outcomes Associated With Hospital-Onset Peripheral Intravenous Catheter-Associated Staphylococcus aureus Bacteremia.

Authors:  Mica Blauw; Betsy Foxman; Juan Wu; Janice Rey; Neelay Kothari; Anurag N Malani
Journal:  Open Forum Infect Dis       Date:  2019-02-27       Impact factor: 3.835

8.  Duration of antibiotic therapy for Staphylococcus aureus bacteraemia: the long and the short of it.

Authors:  E M Eichenberger; V G Fowler; T L Holland
Journal:  Clin Microbiol Infect       Date:  2020-01-20       Impact factor: 13.310

9.  Improved understanding of factors driving methicillin-resistant Staphylococcus aureus epidemic waves.

Authors:  Som S Chatterjee; Michael Otto
Journal:  Clin Epidemiol       Date:  2013-07-04       Impact factor: 4.790

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.